Postoperative Adjuvant Therapy Benefits Non‐pCR Patients Rather Than pCR Patients for Locally Advanced ESCC: A Multicenter Real‐World Study

Postoperative Adjuvant Therapy Benefits Non‐pCR Patients Rather Than pCR Patients for Locally Advanced ESCC: A Multicenter Real‐World Study

ABSTRACT Background There is no unified standard in adjuvant therapy (AT) for patients with esophageal squamous cell carcinoma (ESCC) after neoadjuvant therapy and surgery. We evaluated the significance of AT for these patients and explored its influencing factors. Methods ESCC patients who underwen...

Full description

Saved in:
Bibliographic Details
Main Authors: Defeng Liu, Ao Liu, Longxiang Guo, Yi Li, Yuanlin Li, Yuxiang Chi, Haiqun Lin, Jinming Yu, Minghuan Li
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:Thoracic Cancer
Subjects:
adjuvant therapy
disease‐free survival
esophageal squamous cell carcinoma
immunotherapy
overall survival
Online Access:https://doi.org/10.1111/1759-7714.70021
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1111/1759-7714.70021

Similar Items